Industry association · Germany · EU Transparency Register 833518016005-88
Counts here are a floor, never a total: they cover the 665 consultation files tracked so far (57,774 submissions, mostly 2021–26), so an organization's real filing history is larger, not smaller.
Among the 1518 trade and business associations on this site, they rank #839 by legislative files engaged, a count of participation, not a measure of influence.
Self-declared to the EU Transparency Register (snapshot 14 Oct 2026).
Self-declared to the EU Transparency Register (snapshot 14 Oct 2026); cost bands are floors, not audited totals. Reused under Commission Decision 2011/833/EU.
Track Pro in PolicySpeak: request access →
Work at Pro Generika e.V.? so we know who speaks for it.
Pro Generika e.V. filed 4 positions between 4 Apr 2022 and 11 Jun 2025, across 3 of the 665 legislative files tracked here, attaching a full position paper 4 times.
Per generic product is the association of generic and biosimilar companies in Germany. Our member companies are the guarantor of the German health system’s promise that every patient will have access to modern and affordable drug therapies.
Filed in German · English published by the European Commission
Progeny’s opinion on the revision of EU pharmaceutical legislation (situation as at 7 June 2023) welcomes the fact that, on the basis of the translations of the draft laws that are not yet available, we can comment on EU legislation on a provisional basis.
Filed in German · English published by the European Commission
Consultation on the planned legislative initiative EU Biotech Act (initiative No 14627) Dear Madam and AG Pro Biosimilars is representing the interests of biosimilar companies in Germany. It is open to all companies that develop, produce and supply biosimilars. The working group under the umbrella of Pro Genetic Medicines e.V.
Filed in German · English published by the European Commission
Pro Generika is the German Association of the Generics and Biosimilar Pharmaceutical Industry. It has 17 members covering around 70 % of the German generics market. Our member companies guarantee for the German health system that every patient has access to modern and affordable medicinal therapies.
Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.
Put Pro Generika e.V. next to another organization. Same files, same register facts, side by side. Compare →
Organizations that also filed on at least two of the same consultations. A shared interest in the same dossiers, not evidence of coordination, and we do not suggest any.
Showing 5 of 81.
Everything on this page comes from Pro Generika e.V.’s own submissions to the European Commission. We have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.
Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.